Cargando…
Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma
Background: Chemotherapeutic resistance of glioblastoma has been attributed to a self-renewing subpopulation, the glioma stem cells (GSCs), which is known to be maintained by the Wnt β−catenin pathway. Our previous findings demonstrated that exogeneous addition of the Wnt antagonist, secreted fizzle...
Autores principales: | Bhuvanalakshmi, Gurubharathi, Gamit, Naisarg, Patil, Manasi, Arfuso, Frank, Sethi, Gautam, Dharmarajan, Arun, Prem Kumar, Alan, Warrier, Sudha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356444/ https://www.ncbi.nlm.nih.gov/pubmed/30591679 http://dx.doi.org/10.3390/cancers11010025 |
Ejemplares similares
-
Identification of a Novel Wnt Antagonist Based Therapeutic and Diagnostic Target for Alzheimer’s Disease Using a Stem Cell-Derived Model
por: Patil, Manasi, et al.
Publicado: (2023) -
An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4
por: Varier, Lavanya, et al.
Publicado: (2023) -
iPSC-Derived Glioblastoma Cells Have Enhanced Stemness Wnt/β-Catenin Activity Which Is Negatively Regulated by Wnt Antagonist sFRP4
por: Yasmin, Ishmat Ara, et al.
Publicado: (2023) -
Epigenetic reprogramming converts human Wharton’s jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators
por: Bhuvanalakshmi, G., et al.
Publicado: (2017) -
Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4
por: Bhuvanalakshmi, G., et al.
Publicado: (2017)